Skip to content

Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients

Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07090980
Acronym
epilepsy
Enrollment
70
Registered
2025-07-29
Start date
2024-11-25
Completion date
2025-05-17
Last updated
2025-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Therapy, Epilepsy, Self Management, Stigma

Keywords

Epilepsy, podcast, nursing, stigma, self-management, drug perception

Brief summary

Seventy epilepsy patients who presented to Gaziosmanpaşa Training and Research Hospital as outpatients (diagnosed at least 3 months prior, taking at least one medication, and having access to the internet) were randomly assigned to two groups. 35 patients were assigned to the experimental group, and 35 patients to the control group. All patients were asked to complete a sociodemographic form, self-management form, medication adherence form, and stigma form as pre-tests. The experimental group was exposed to an epilepsy education podcast recorded by the researcher via Spotify. The control group received routine outpatient education provided by the doctor. The same tests were repeated at 1 and 3 months, and the effectiveness of the education was evaluated. Differences between the two groups and changes over time were monitored.

Interventions

OTHERepilepsy education via podcast

Epilepsy education via podcast has never been provided in any clinical study in Turkey before. By providing education via podcast, we have made health education more accessible and repeatable.

Sponsors

Istanbul Sabahattin Zaim University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Two groups were randomly assigned as the experimental and control groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Volunteer to participate in the study * 18 years of age * Diagnosed with epilepsy at least 3 months ago * Taking at least one antiepileptic drug

Exclusion criteria

* Being diagnosed with mental retardation * Having language and communication barriers * Not having sufficient equipment

Design outcomes

Primary

MeasureTime frameDescription
first month results1 month resultMembers of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the Patient Information Form, the Medication Beliefs Questionnaire, the Feeled Stigma Scale, and the Self-Management Scale. The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.

Secondary

MeasureTime frameDescription
third month resultthree monthsMembers of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the Patient Information Form, the Medication Beliefs Questionnaire, the Feeled Stigma Scale, and the Self-Management Scale. The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026